Cargando…

Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report

Pharmacogenomic (PGx) information can guide drug and dose selection, optimize therapy outcomes, and/or decrease the risk of adverse drug events (ADEs). This report demonstrates the impact of a pharmacist-led medication evaluation, with PGx assisted by a clinical decision support system (CDSS), of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Toro-Pagán, Nicole Marie, Matos, Adriana, Thacker, David, Turgeon, Jacques, Amin, Nishita Shah, Michaud, Veronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466444/ https://www.ncbi.nlm.nih.gov/pubmed/34577878 http://dx.doi.org/10.3390/medicina57090955

Ejemplares similares

Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report
por: Muhn, Selina, et al.
Publicado: (2022)

Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report
por: Del Toro-Pagán, N. M., et al.
Publicado: (2022)

Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis
por: Pizzolato, Katie, et al.
Publicado: (2022)

Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
por: Pizzolato, Katie, et al.
Publicado: (2021)

Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall
por: Russell, Joshua, et al.
Publicado: (2023)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
por: Jessop, Jayson P., et al.
Publicado: (2023)

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
por: Mostafa, Sam, et al.
Publicado: (2021)

Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices
por: Luke, Miles J., et al.
Publicado: (2021)

Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics
por: Bain, Kevin T., et al.
Publicado: (2019)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Dasatinib-induced nephrotic syndrome: a case of phenoconversion?
por: Mandac Rogulj, Inga, et al.
Publicado: (2019)

Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2016)

Virtual Pharmacist: A Platform for Pharmacogenomics
por: Cheng, Ronghai, et al.
Publicado: (2015)

Basic Concepts in Genetics and Pharmacogenomics for Pharmacists
por: Orrico, Kathleen B
Publicado: (2019)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students
por: Mehtar, Mira, et al.
Publicado: (2022)

CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2012)

The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis
por: Fukumoto, Jutaro, et al.
Publicado: (2016)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
por: Klomp, Sylvia D., et al.
Publicado: (2020)

Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion
por: Morelli, Marco B., et al.
Publicado: (2019)

Sleep Disturbances and Phenoconversion in Patients with REM Sleep Behavior Disorder
por: Jo, Hyunjin, et al.
Publicado: (2021)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
por: den Uil, Manon G., et al.
Publicado: (2023)

Development of the pharmacogenomics and genomics literacy framework for pharmacists
por: Rahma, Azhar T., et al.
Publicado: (2021)

The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics
por: Maruf, Abdullah Al, et al.
Publicado: (2023)

Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder
por: Zolfaghari, Sheida, et al.
Publicado: (2022)

Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education
por: Kisor, David F, et al.
Publicado: (2019)

The impact of CYP2C19 genotype on phenoconversion by concomitant medication
por: de Jong, Laura M., et al.
Publicado: (2023)

Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
por: Orso, Beatrice, et al.
Publicado: (2023)

Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
por: Frick, Amber, et al.
Publicado: (2016)

Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation
por: Bright, David, et al.
Publicado: (2020)

Pharmacists’ Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia
por: Alhaddad, Zahra Abdulathim, et al.
Publicado: (2022)

Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
por: Ghazal, Heba, et al.
Publicado: (2023)

A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
por: Macciardi, Fabio, et al.
Publicado: (2022)

Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder
por: Ganapathy S., Ranjani, et al.
Publicado: (2022)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Clinical Pharmacists’ Involvement in Pharmacogenomics Testing and Related Services in China
por: Hu, Xiaowen, et al.
Publicado: (2022)

Clinical Pharmacists’ Knowledge of and Attitudes toward Pharmacogenomic Testing in China
por: Nie, Xiaoyan, et al.
Publicado: (2022)

Knowledge, Attitude, and Perceptions of Pharmacists and Pharmacy Students towards Pharmacogenomics in Zimbabwe
por: Muzoriana, Nyasha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v5075fqbmi9qs9qvhjljk5h6ot